Table 2.
Clinical and biological characteristics of 25 (out of 88) SLE nephritis patients with serum sIL7R concentrations above the renal cut-off
| Age | Gender | sIL7R (pmol/mL) | dsDNA Ab titres (U/mL) | Serum C3 (mg/dL) | UPC ratio | Disease status |
|---|---|---|---|---|---|---|
| 26 | F | 4587 | 167 | 50 | 2.0 | Renal BILAG A |
| 26 | M | 3035 | 32.5 | 68 | 1.3 | Renal and mucocutaneous BILAG A |
| 46 | F | 2658 | 289 | 46 | 5.4 | Renal BILAG A, 1 month later |
| 44 | F | 2241 | 125 | 60 | 0.9 | Renal and neurological BILAG A, 2 months later |
| 49 | F | 2232 | 43.8 | 89 | 0.2 | Renal BILAG D |
| 47 | F | 2220 | 110.7 | 81 | 0.13 | Renal BILAG A, 3 months later |
| 56 | M | 2119 | 24.8 | 150 | 0.2 | Renal BILAG C |
| 27 | F | 1810 | 7.5 | 90 | 0.3 | Renal BILAG C |
| 29 | F | 1803 | 67 | 65.8 | 0.1 | Renal BILAG D |
| 27 | F | 1647 | 158.5 | 47 | 0.8 | Renal BILAG B |
| 41 | F | 1636 | 1520 | 57 | 2.1 | Renal, mucocutaneous and general BILAG A |
| 43 | F | 1557 | 5.3 | 97 | 0.2 | Renal BILAG D |
| 51 | F | 1495 | 38.7 | 134 | 0.6 | Renal BILAG D |
| 47 | F | 1466 | 5.9 | 101 | 0.2 | Renal BILAG D |
| 28 | F | 1348 | 255 | 69 | 2.1 | Renal and general BILAG A, 1 month later |
| 33 | F | 1291 | 161 | 53 | 1.9 | Renal BILAG A |
| 24 | F | 1175 | 7 | 124 | 0.1 | Renal BILAG B |
| 19 | F | 1155 | 179 | 62 | 0.17 | Renal and general BILAG A |
| 62 | F | 1156 | 6.3 | 96 | 0.05 | Renal BILAG D |
| 50 | F | 1154 | 7 | 61 | 0.1 | Renal BILAG C |
| 28 | F | 1148 | 2092 | 74 | 2.8 | Renal and general BILAG A, 2 months later |
| 31 | F | 1128 | 16.3 | 52 | 0.1 | Renal BILAG C |
| 61 | F | 1110 | 57 | 6 | 0.1 | Renal BILAG D |
| 47 | F | 1109 | 67.4 | 106 | 0.5 | Renal BILAG A, 3 months later |
| 25 | F | 1088 | 6.2 | 114 | 5.6 | Renal and general BILAG A |
sIL7R, soluble form of the interleukin-7 receptor; UPC, urinary protein to creatine.